LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Aged Patients Should Benefit from Neuronal Stem Cell Therapy

By LabMedica International staff writers
Posted on 28 Jun 2016
Image: The hippocampus, located in the medial temporal lobe of the brain (Photo courtesy of Wikimedia Commons).
Image: The hippocampus, located in the medial temporal lobe of the brain (Photo courtesy of Wikimedia Commons).
Neurodegenerative researchers have demonstrated the potential of stem cell therapy for treating elderly individuals with age-related neurological illnesses.

Investigators at the Texas A&M Health Science Center (Temple, Texas, USA) used donor cells from the sub-ventricular zone of the brain to prepare neural stem cells. These stem cells were grafted into the hippocampus of both young and old (the equivalent of about 70 years old in human terms) rats.

Results published in the May 18, 2016, online edition of the journal Stem Cells Translational Medicine revealed that advanced age of the host at the time of grafting had no major adverse effects on engraftment, migration, and differentiation of grafted subventricular zone-neural stem cells (SVZ-NSCs) in the intact hippocampus. Both young and aged hippocampi promoted excellent engraftment, migration, and differentiation of SVZ-NSC graft-derived cells.

In addition, SVZ-NSC grafts established neurogenic niches in non-neurogenic regions, generating new neurons for extended periods after grafting. This phenomenon would be beneficial to transplant recipients if these niches could continuously generate new neurons and glia in the grafted hippocampus, as newly generated neurons and glia would be expected to improve, not only the microenvironment, but also the plasticity and function of the aged hippocampus.

“We are very excited to see that the aged hippocampus can accept grafted neural stem cells as superbly as the young hippocampus does and this has implications for treating age-related neurodegenerative disorders,” said senior author Dr. Bharathi Hattiangady, assistant professor of molecular and cellular medicine at the Texas A&M Health Science Center. “It is interesting that even neural stem cell niches can be formed in the aged hippocampus. What was really exciting is that in both old and young brains, a small percentage of the grafted cells retained their "stemness" feature and continuously produced new neurons. They are still producing new neurons at least three months after implantation, and these neurons are capable of migrating to different parts of the brain.”

Related Links:
Texas A&M Health Science Center


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more